
FDA Endorses Donanemab, Revolutionary Alzheimer’s Treatment
The unanimous 11-0 FDA vote clears an exciting path for this new Alzheimer’s drug.

The unanimous 11-0 FDA vote clears an exciting path for this new Alzheimer’s drug.

South Korea joined other countries in approving LEQEMBI® (generic lecanemab) for mild cognitive impairment, mild and early Alzheimer’s. Learn how Leqembi is treating Alzheimer’s around the world.

In a span of 40 years, why did average brain size increase and dementia rates drop? A new UC-Davis study explores environmental factors behind this silent revolution.

“People with dementia living in nursing homes and in the community were prescribed less and we did not detect negative health impacts for these groups.”

LEQEMBI® is the newest Alzheimer’s drug. It is administered in hospitals via IV. Biogen applied to the FDA for approval of a home version using an “Autoinjector”. See how it works and learn its advantages.

The newest and most promising drug to fight Alzheimer’s is Leqembi. Carolyn Davis is giving it a try. Learn about the promise, the risks and how it has restored her hope,

Scheduled to begin on May 9, 2024, six new monthly sessions are now available in this free Continuing Education Program.

People with dementia may be even more vulnerable to fraud and scams than previously thought, according to an NIA study. See the story of one victim with a happy ending. Read the research.

Galantamine treats Alzheimer’s. Artificial intelligence and biosensors may pave the way to make this drug faster and cheaper.

A long, long time ago (1930), brains were smaller. Are today’s bigger brains connected to improvements in rates of dementia?

SURVEY RESULTS: HAPPY MOTHER’S DAY USA – The right words can help us rise to dementia’s challenges. Relish these valuable pieces of wisdom, gathered from grandmothers and mothers across the country.

(VIDEO) BOOK-OF-THE-WEEK: Dr. Gayatri Devi, Neurologist at NY’s Lenox Hill Hospital, released “The Spectrum of Hope: An Optimistic and New Approach to Alzheimer’s Disease and Other Dementias.” It details a plan for people with Alzheimer’s to live more empowered and productive lives.

Triheptanoin is available as a supplement or by prescription. A series of studies suggest it improves brain energy metabolism for people with Huntington’s disease. Learn how.

An intriguing study of 120 grandmothers might surprise you. Doctors know socially engaged people have better cognition and less dementia. But can a person get too much of a good thing? What’s the right balance?

Enjoy this great duet between a musician with dementia and his son. A triumph of spirit over Alzheimer’s! Sing-a-long if you like!

It looks like a sneeze cannot give anyone Alzheimer’s. While Alzheimer’s abnormal disease proteins do spread from cell-to-cell, they are not “infectious”. Check out the facts.

TEEPA CARE VIDEO: Learn about Alzheimer’s 6 stages. Teepa Snow shows what to expect, while keeping the focus on the person for whom you care.
No spam, only news and updates.



We use cookies and similar technologies to improve your experience, understand how our content is used, and support relevant advertising that helps keep Alzheimer’s Weekly free to readers. You can choose to accept, deny, or manage your preferences at any time. Declining certain cookies may affect features such as embedded videos, comments, and personalized advertising.